Update in Hospital Medicine 2025

Update in Hospital Medicine is a live online course, utilizing live streaming, electronic Q&A, and other remote learning technologies.

Overview

This 4-day intensive program is designed to update busy practitioners on current best practices in hospital medicine. The curriculum covers over 30 core topics, with a focus on the practical management of common problems.

2025 Program Highlights

• Comprehensive review of inpatient antibiotic therapy
• Thrombolysis in acute stroke: Are we going to need a bigger window?
• New data on optimal treatment duration for skin and soft tissue infections
• Treating acute and chronic pain in patients with substance use disorders
• Less is more in the long run? DAPT vs. monotherapy in ACS
• State-of-the-art management of systolic and diastolic heart failure
• Oral fecal microbiota therapy: New first-line for C. difficile?
• The jury is out: Anticoagulation in silent atrial fibrillation with a low CHA2DS2-VASc
• Differentiating skin infections and mimics in hospitalized patients
• GLP-1 agonists for weight loss: Hot takes for the hospitalist
• Trauma-informed care in the hospital
• Anti-racism in hospital medicine, from triage to care transitions
• Covert hepatic encephalopathy: More common than you think
• New kid on the block: Cystatin C for GFR
• Thrombolytics vs. DAPT for mild strokes: Weighing the risks and benefits
• Best practices in pharmacotherapy for agitated delirium
• Injectable therapy for HIV
• Harm reduction: Reducing the risk of opiate overdose at discharge
• Evolving strategies for hepatorenal syndrome: Terlipressin
• Eliminate drug-resistant infections with this one weird trick
• Delirium: An ounce of prevention is worth a pound of cure
• Best practices and risk mitigation surrounding patient-directed discharges
• Do they really need admission? Identifying the low-risk PE patient
• Should you switch anticoagulants in patients with breakthrough strokes?
• The debate continues: Cefepime vs. piperacillin-tazobactam for sepsis
• Are DOACs the preferred anticoagulant in patients with cancer?
• Evidence-based tools for risk stratification in syncope
• Microdosing protocols for buprenorphine induction
• Evidence-based strategies for serious illness conversations in the hospital
• To DAPT or not to DAPT: Antiplatelet therapy in stroke and TIA
• HELLP me: Managing medical complications in pregnant and postpartum patients
• The never-ending story: Steroids in sepsis
• Are GLP-1 agonists and SGLT2 inhibitors kidney-saving medications?
• Capacity assessment: Can this patient make their own decisions?